China’s Breakthrough in Innovative Drugs: Behind the $15.3 Billion Licensing Deal for Global Pricing Power March 4, 2026 — 14:30
China’s Leading Innovative Drug Company Makes Strides, Amasses Over $20 Billion in the U.S. March 1, 2026 — 00:30
Understanding Pax Silica and the Importance of India’s Inclusion in the AI Supply Chain Alliance February 20, 2026 — 16:35
Montage Technology Makes a Splash with Over 50% Surge in Hong Kong Market Debut February 9, 2026 — 14:20
AstraZeneca’s Billion-dollar Investment Sets New Standard for International Pharmaceutical Companies in China January 31, 2026 — 21:30